Familial thoracic aortic aneurysm and dissection associated with Marfan-related gene mutations: case report of a family with two gene mutations.
暂无分享,去创建一个
T. Morisaki | H. Morisaki | K. Sadamatsu | K. Morishige | H. Yasunaga | T. Yamawaki | K. Nagaoka | H. Tashiro | Kazuhiro Nagaoka
[1] M Claustres,et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. , 2007, American journal of human genetics.
[2] J. Dean. Marfan syndrome: clinical diagnosis and management , 2007, European Journal of Human Genetics.
[3] P. Byers,et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.
[4] George H. Thomas,et al. Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .
[5] Marc K. Halushka,et al. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.
[6] P. Robinson,et al. The molecular genetics of Marfan syndrome and related disorders , 2006, Journal of Medical Genetics.
[7] K. Sadamatsu,et al. Intimal flap of ascending aortic dissection with valve-like motion diagnosed by transesophageal echocardiography. , 2005, Internal medicine.
[8] S. Shete,et al. Mutations in Transforming Growth Factor-&bgr; Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections , 2005, Circulation.
[9] Bruce Bennetts,et al. Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy , 2004, Human mutation.
[10] D. Arking,et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.
[11] D. Arking,et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.